Supports Australian participation in international, investigator-initiated clinical trials by establishing and coordinating Australian trial sites and generating high-quality evidence on novel treatments, drugs, or devices in usual-care settings to inform adoption in Australia. Administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing.
Eligibility Criteria:
-
Intended for eligible Australian research organisations and investigators involved in international, investigator-initiated clinical trials.
-
Applications must align with the Clinical Trials Activity Initiative aims (increase trial activity, improve evidence base, expand patient access).
-
Submission via Sapphire in accordance with NHMRC requirements and institutional policies.
Funding Details:
-
Grants of financial assistance under the Medical Research Future Fund (MRFF).
-
Supports:
-
Australian involvement in international collaborative trials (set-up and coordination of Australian site/s).
-
Generation of real-world evidence in usual-care settings on novel health treatments, drugs, or devices.
-
-
Anticipated outcome: improved health and wellbeing for Australians through increased access to evidence-based, effective care.
Deadline:
-
Applications Open: 20 February 2025.
-
Minimum Data Due: Round 1 – 2 July 2025; Round 2 – 10 December 2025.
-
Applications Close: Round 1 – 30 July 2025; Round 2 – 4 February 2026.
Where To Go For Further Information: